Literature DB >> 34569519

Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion for Micro-Preemie Infants with Septic Shock. Is Extended Duration Better than Early Start? Comment to the Letter to the Editor of Nishizaki and Colleagues.

Chieko Mitaka1, Toshiaki Iba2, Claudio Ronco3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34569519      PMCID： PMC9153337          DOI： 10.1159/000518904

Source DB:  PubMed          Journal:  Blood Purif        ISSN： 0253-5068            Impact factor:   3.348


× No keyword cloud information.
  5 in total

Review 1.  International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics.

Authors:  Brahm Goldstein; Brett Giroir; Adrienne Randolph
Journal:  Pediatr Crit Care Med       Date:  2005-01       Impact factor: 3.624

2.  Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion for Micro-Preemie Infants: Is Extended Duration Better than Early Start?

Authors:  Naoto Nishizaki; Kaoru Obinata; Toshiaki Shimizu
Journal:  Blood Purif       Date:  2021-09-15       Impact factor: 2.614

3.  Polymyxin B-immobilized fiber column direct hemoperfusion and continuous hemodiafiltration in premature neonates with systemic inflammatory response syndrome.

Authors:  Yoshinobu Maede; Satoshi Ibara; Takuya Tokuhisa; Chie Ishihara; Eiji Hirakawa; Takako Matsui; Daijiro Takahashi; Seiro Machigashira; Hisanori Minakami
Journal:  Pediatr Int       Date:  2016-07-24       Impact factor: 1.524

4.  In Vitro Study of Endotoxin Adsorption by a Polymyxin B-Immobilized Fiber Column.

Authors:  Chizuru Yamashita; Kazuhiro Moriyama; Daisuke Hasegawa; Yu Kato; Toshikazu Sakai; Takahiro Kawaji; Yasuyo Shimomura; Yasuyoshi Kurimoto; Mariko Nagata; Osamu Nishida
Journal:  Blood Purif       Date:  2018-07-03       Impact factor: 2.614

5.  Impact of Extended Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion on Hemodynamics, Vasoactive Substance Requirement, and Pulmonary Oxygenation in Patients with Sepsis: An Observational Study.

Authors:  Chieko Mitaka; Makio Kusao; Izumi Kawagoe; Daizoh Satoh; Toshiaki Iba; Claudio Ronco
Journal:  Blood Purif       Date:  2021-04-28       Impact factor: 2.614
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.